Management of Gout: Targeting Pain or Metabolic Control

    April 2026 in “ International Journal of Research and Review ”
    G. R. Subbu, Martin M, Milaniya M, Raveendran A
    Image
    Studysummary This article reviews current literature and suggests that managing gout with early urate-lowering therapy, within a 'treat-to-target' strategy, can help prevent systemic complications and address the rising prevalence of hyperuricemia-related diseases.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The article emphasizes that gout is primarily a metabolic disease with widespread systemic effects, necessitating early intervention and a treat-to-target approach to urate-lowering therapy. This strategy aims to reduce serum uric acid levels below 6 mg/dL to prevent disease progression and related health issues, rather than just managing acute symptoms like pain. The rising prevalence of hyperuricemia-related diseases is linked to lifestyle changes, and addressing gout's metabolic origins can mitigate its impact on various bodily systems. Early identification and treatment of hyperuricemia are crucial, as gout is both preventable and curable with proper management.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results